S

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250

Watchlist Manager
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Watchlist
Price: 104 800 KRW -6.26% Market Closed
Market Cap: 2.4T KRW
Have any thoughts about
Sam Chun Dang Pharm Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Sam Chun Dang Pharm Co Ltd stock under the Base Case scenario is 11 241.66 KRW. Compared to the current market price of 104 800 KRW, Sam Chun Dang Pharm Co Ltd is Overvalued by 89%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
11 241.66 KRW
Overvaluation 89%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Sam Chun Dang Pharm Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Sam Chun Dang Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Sam Chun Dang Pharm Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Sam Chun Dang Pharm Co Ltd
KR
Pharmaceuticals
Market Cap
2.4T KRW
IPO
Oct 4, 2000
Employees
-
Korea
Market Cap
2.4T KRW
Industry
Pharmaceuticals
IPO
Oct 4, 2000

SAM CHUN DANG PHARM Co., Ltd. engages in the manufacture of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2000-10-04. CO., LTD is a Korea-based company mainly engaged in the manufacture of prescription medicines. The Company’s products portfolio consists of antibiotics used for treatment of sepsis, respiratory diseases and others; circulatory disease medicines including cardiovascular and endocrine medicaments used for treatment of diabetes, hypertension, angina and others under the brand names of Glilazide and Atenolol; digestive medicines used for treatment of duodenal ulcer, gastritis and others; ophthalmological agents used for treatment of conjunctivitis, keratitis and other eye inflammation under the brand names of Ofus and Toracin, and anti-inflammatories used to release postoperative pains under the brand name Barotase and others.

[ Read More ]

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Sam Chun Dang Pharm Co Ltd

Provide an overview of the primary business activities
of Sam Chun Dang Pharm Co Ltd.

What unique competitive advantages
does Sam Chun Dang Pharm Co Ltd hold over its rivals?

What risks and challenges
does Sam Chun Dang Pharm Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sam Chun Dang Pharm Co Ltd.

Provide P/S
for Sam Chun Dang Pharm Co Ltd.

Provide P/E
for Sam Chun Dang Pharm Co Ltd.

Provide P/OCF
for Sam Chun Dang Pharm Co Ltd.

Provide P/FCFE
for Sam Chun Dang Pharm Co Ltd.

Provide P/B
for Sam Chun Dang Pharm Co Ltd.

Provide EV/S
for Sam Chun Dang Pharm Co Ltd.

Provide EV/GP
for Sam Chun Dang Pharm Co Ltd.

Provide EV/EBITDA
for Sam Chun Dang Pharm Co Ltd.

Provide EV/EBIT
for Sam Chun Dang Pharm Co Ltd.

Provide EV/OCF
for Sam Chun Dang Pharm Co Ltd.

Provide EV/FCFF
for Sam Chun Dang Pharm Co Ltd.

Provide EV/IC
for Sam Chun Dang Pharm Co Ltd.

Show me price targets
for Sam Chun Dang Pharm Co Ltd made by professional analysts.

What are the Revenue projections
for Sam Chun Dang Pharm Co Ltd?

How accurate were the past Revenue estimates
for Sam Chun Dang Pharm Co Ltd?

What are the Net Income projections
for Sam Chun Dang Pharm Co Ltd?

How accurate were the past Net Income estimates
for Sam Chun Dang Pharm Co Ltd?

What are the EPS projections
for Sam Chun Dang Pharm Co Ltd?

How accurate were the past EPS estimates
for Sam Chun Dang Pharm Co Ltd?

What are the EBIT projections
for Sam Chun Dang Pharm Co Ltd?

How accurate were the past EBIT estimates
for Sam Chun Dang Pharm Co Ltd?

Compare the revenue forecasts
for Sam Chun Dang Pharm Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sam Chun Dang Pharm Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sam Chun Dang Pharm Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sam Chun Dang Pharm Co Ltd compared to its peers.

Compare the P/E ratios
of Sam Chun Dang Pharm Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Sam Chun Dang Pharm Co Ltd with its peers.

Analyze the financial leverage
of Sam Chun Dang Pharm Co Ltd compared to its main competitors.

Show all profitability ratios
for Sam Chun Dang Pharm Co Ltd.

Provide ROE
for Sam Chun Dang Pharm Co Ltd.

Provide ROA
for Sam Chun Dang Pharm Co Ltd.

Provide ROIC
for Sam Chun Dang Pharm Co Ltd.

Provide ROCE
for Sam Chun Dang Pharm Co Ltd.

Provide Gross Margin
for Sam Chun Dang Pharm Co Ltd.

Provide Operating Margin
for Sam Chun Dang Pharm Co Ltd.

Provide Net Margin
for Sam Chun Dang Pharm Co Ltd.

Provide FCF Margin
for Sam Chun Dang Pharm Co Ltd.

Show all solvency ratios
for Sam Chun Dang Pharm Co Ltd.

Provide D/E Ratio
for Sam Chun Dang Pharm Co Ltd.

Provide D/A Ratio
for Sam Chun Dang Pharm Co Ltd.

Provide Interest Coverage Ratio
for Sam Chun Dang Pharm Co Ltd.

Provide Altman Z-Score Ratio
for Sam Chun Dang Pharm Co Ltd.

Provide Quick Ratio
for Sam Chun Dang Pharm Co Ltd.

Provide Current Ratio
for Sam Chun Dang Pharm Co Ltd.

Provide Cash Ratio
for Sam Chun Dang Pharm Co Ltd.

What is the historical Revenue growth
over the last 5 years for Sam Chun Dang Pharm Co Ltd?

What is the historical Net Income growth
over the last 5 years for Sam Chun Dang Pharm Co Ltd?

What is the current Free Cash Flow
of Sam Chun Dang Pharm Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sam Chun Dang Pharm Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sam Chun Dang Pharm Co Ltd

Current Assets 239B
Cash & Short-Term Investments 150B
Receivables 36.8B
Other Current Assets 52.2B
Non-Current Assets 254.2B
Long-Term Investments 30.5B
PP&E 96.5B
Intangibles 109.2B
Other Non-Current Assets 18.1B
Current Liabilities 58.3B
Accounts Payable 4.6B
Accrued Liabilities 10.9B
Short-Term Debt 22.5B
Other Current Liabilities 20.3B
Non-Current Liabilities 159.5B
Long-Term Debt 36.4B
Other Non-Current Liabilities 123B
Efficiency

Earnings Waterfall
Sam Chun Dang Pharm Co Ltd

Revenue
208.2B KRW
Cost of Revenue
-109.5B KRW
Gross Profit
98.7B KRW
Operating Expenses
-94.5B KRW
Operating Income
4.2B KRW
Other Expenses
884m KRW
Net Income
5.1B KRW

Free Cash Flow Analysis
Sam Chun Dang Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sam Chun Dang Pharm Co Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
ROE is Increasing
Positive 1-Year Revenue Growth
40/100
Profitability
Score

Sam Chun Dang Pharm Co Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sam Chun Dang Pharm Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Negative Net Debt
70/100
Solvency
Score

Sam Chun Dang Pharm Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sam Chun Dang Pharm Co Ltd

There are no price targets for Sam Chun Dang Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Sam Chun Dang Pharm Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sam Chun Dang Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Sam Chun Dang Pharm Co Ltd stock?

The intrinsic value of one Sam Chun Dang Pharm Co Ltd stock under the Base Case scenario is 11 241.66 KRW.

Is Sam Chun Dang Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 104 800 KRW, Sam Chun Dang Pharm Co Ltd is Overvalued by 89%.

Back to Top